Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4365014)

Published in PLoS One on March 18, 2015

Authors

Zai Ahmad1, Lukasz Jasnos2, Veronica Gil1, Louise Howell2, Albert Hallsworth1, Kevin Petrie1, Tomoyuki Sawado2, Louis Chesler1

Author Affiliations

1: Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.
2: Division of Molecular Pathology, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.

Articles cited by this

Identification of human brain tumour initiating cells. Nature (2004) 38.87

Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02

Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88

Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56

Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell (2008) 5.06

Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J (1997) 4.99

Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82

Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77

Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron (2000) 4.17

Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13

Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron (2000) 3.91

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88

N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev (2002) 3.71

The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton (1990) 3.25

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell (2009) 3.11

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol (2009) 3.01

Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A (2003) 2.72

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev Biol (1996) 2.68

Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell (2012) 2.45

Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development (2003) 2.42

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A (2013) 2.25

A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell (2012) 2.15

An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12

Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol (1985) 2.01

Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc Natl Acad Sci U S A (1999) 1.90

Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell (2013) 1.85

Pleiotropic role for MYCN in medulloblastoma. Genes Dev (2010) 1.84

Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res (2009) 1.79

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma. Cancer Res (2006) 1.70

N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res (2006) 1.64

CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One (2009) 1.50

Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics (1999) 1.40

The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors. Dev Cell (2005) 1.34

Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. Acta Neuropathol (2011) 1.32

Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol Cell Neurosci (2004) 1.24

OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet (2001) 1.19

Role of MYC in Medulloblastoma. Cold Spring Harb Perspect Med (2013) 1.10

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease. Cancer Cell (2014) 1.08

Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts. Acta Neuropathol (2014) 1.06

Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res (1997) 1.03

Medulloblastoma stem cells: modeling tumor heterogeneity. Cancer Lett (2012) 0.86

Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res (2014) 0.85

Three down and one to go: modeling medulloblastoma subgroups. Cancer Cell (2012) 0.85

Identifying division symmetry of mouse embryonic stem cells: negative impact of DNA methyltransferases on symmetric self-renewal. Stem Cell Reports (2013) 0.85

Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma. J Clin Oncol (2011) 0.81

Determining cell division symmetry through the dissection of dividing cells using single-cell expression analysis. Nat Protoc (2014) 0.78